A US judge in Missouri on Friday approved German chemical giant Bayer's $7.25 billion (€6.60 billion) settlement of lawsuits alleging that its Roundup weedkiller causes cancer. Judge Timothy Boyer of a state court in St Louis found the agreement "fair, reasonable, and adequate" and overruled objections that payouts to individual victims would be too low.
The agreement covers tens of thousands of people who say they developed non-Hodgkin lymphoma, a type of blood cancer, after using Roundup, as well as people who may be diagnosed in the future. Bayer will pay up to $7.25 billion into a special fund over 21 years, with individual payments expected to average between $10,000 and $165,000 depending on factors including age, severity of illness and length of exposure. Judge Boyer said delays could force seriously ill victims, including those with terminal cancer, to wait an indeterminate number of years to be paid.S1S2
Bayer had faced approximately 65,000 claims in US state and federal courts. The company bought Monsanto, which produces Roundup, for $63 billion in 2018, and its share price has fallen 46% since then. Bayer previously settled much of the litigation for $10.9 billion in 2020, but a $1.25 billion settlement to resolve future claims failed to win court approval.S1S2
The approval follows a June ruling by the US Supreme Court, which overturned a $1.25 million jury award to Missouri man John Durnell. In a 7-2 decision, the court agreed with Bayer that federal pesticide law barred failure-to-warn claims brought under state law. Bayer's CEO, Bill Anderson, called the final approval "a decisive milestone" in managing pending and future Roundup litigation, while lead plaintiffs' lawyer Christopher Seeger said the victims had waited more than a decade for compensation. The ruling could still be appealed, and about 200 cases remain in federal courts outside the settlement.S1S2